Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals EPS Diluted (Quarterly) : 0.5022 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.5022 |
| December 31, 2025 | 0.4136 |
| September 30, 2025 | 0.4153 |
| June 30, 2025 | 0.4086 |
| March 31, 2025 | 0.4469 |
| December 31, 2024 | 0.443 |
| September 30, 2024 | 0.3499 |
| June 30, 2024 | 0.3272 |
| March 31, 2024 | 0.1886 |
| December 31, 2023 | 0.3063 |
| September 30, 2023 | -0.2887 |
| June 30, 2023 | 0.3322 |
| March 31, 2023 | 0.2594 |
| December 31, 2022 | 0.2244 |
| September 30, 2022 | 0.2031 |
| June 30, 2022 | 0.1979 |
| March 31, 2022 | 0.1214 |
| December 31, 2021 | 0.0854 |
| September 30, 2021 | 0.0958 |
| June 30, 2021 | 0.1131 |
| March 31, 2021 | 0.0718 |
| December 31, 2020 | 0.1081 |
| September 30, 2020 | 0.4076 |
| June 30, 2020 | 0.0916 |
| March 31, 2020 | 0.0979 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0744 |
| September 30, 2019 | 0.1273 |
| June 30, 2019 | 0.1035 |
| March 31, 2019 | -0.0063 |
| December 31, 2018 | -0.1411 |
| September 30, 2018 | -0.0764 |
| June 30, 2018 | -0.06 |
| March 31, 2018 | -0.0556 |
| December 31, 2017 | -0.06 |
| September 30, 2017 | -0.05 |
| June 30, 2017 | -0.05 |
| March 31, 2017 | -0.06 |
| December 31, 2016 | -0.05 |
| September 30, 2016 | -0.05 |
| June 30, 2016 | -0.06 |
| March 31, 2016 | -0.07 |
| December 31, 2015 | -0.07 |
| September 30, 2015 | -0.05 |
| June 30, 2015 | -0.06 |
| March 31, 2015 | -0.07 |
| December 31, 2014 | -0.05 |
| September 30, 2014 | -0.07 |
| June 30, 2014 | -0.05 |
| March 31, 2014 | -0.07 |
| December 31, 2013 | -0.03 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.0737 |
| Indivior Pharmaceuticals, Inc. | 0.9839 |
| Exelixis, Inc. | 0.8166 |
| United Therapeutics Corp. | 7.271 |
| Krystal Biotech, Inc. | 1.786 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 63.73M |
| Revenue (Quarterly) | 149.39M |
| Total Expenses (Quarterly) | 85.66M |
| Enterprise Value | 3.094B |
| Gross Profit Margin (Quarterly) | 83.82% |
| Profit Margin (Quarterly) | 42.66% |
| Earnings Yield | 5.52% |
| Operating Earnings Yield | 6.68% |
| Normalized Earnings Yield | 5.471 |